ng-nitroarginine methyl ester has been researched along with Toxemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flynn, JT; Herndon, DN; Hinder, F; Meyer, J; Stothert, J; Traber, DL; Traber, LD | 1 |
Fahey, TJ; Fantini, GA; Shires, GT; Yoshioka, T | 1 |
Farhood, A; Guido, DM; Jaeschke, H; Mathews, WR; Wang, Y | 1 |
3 other study(ies) available for ng-nitroarginine methyl ester and Toxemia
Article | Year |
---|---|
Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Cardiac Output; Chronic Disease; Escherichia coli; Female; Lactates; Lactic Acid; Lipopolysaccharides; Microspheres; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Regional Blood Flow; Sheep; Thromboxane B2; Toxemia; Vascular Resistance; Vasodilation | 1994 |
The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin.
Topics: Animals; Arginine; Cardiovascular Diseases; Endotoxins; Enzyme Inhibitors; Hemodynamics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Shock, Septic; Toxemia; Tumor Necrosis Factor-alpha | 1996 |
Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia.
Topics: Alanine Transaminase; Animals; Arginine; Endotoxins; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; Ischemia; Lipid Peroxidation; Liver; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred F344; Reperfusion Injury; Toxemia; Vasoconstriction | 1995 |